These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15796154)

  • 1. Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.
    Cory AH; Cory JG
    In Vivo; 2005; 19(1):31-5. PubMed ID: 15796154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.
    Cory AH; Cory JG
    Anticancer Res; 2001; 21(6A):3807-11. PubMed ID: 11911251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells.
    Hall JG; Cory AH; Hickerson DH; Cory JG
    Anticancer Res; 2001; 21(1A):173-80. PubMed ID: 11299731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
    Somerville L; Cory JG
    Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors.
    Somerville L; Cory JG
    Anticancer Res; 1999; 19(2A):1021-6. PubMed ID: 10368649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells.
    He AW; Cory JG
    Int J Oncol; 1999 May; 14(5):891-5. PubMed ID: 10200338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH; Cory JG
    Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway.
    Dinkova-Kostova AT; Cory AH; Bozak RE; Hicks RJ; Cory JG
    Cancer Lett; 2007 Jan; 245(1-2):341-9. PubMed ID: 16517063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to apoptosis induced by 7-hydroxystaurosporine.
    Somerville L; Cory JG
    Int J Oncol; 2000 Oct; 17(4):797-803. PubMed ID: 10995894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells.
    He AW; Cory JG
    Oncol Res; 1998; 10(9):455-64. PubMed ID: 10223621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: necrosis vs. apoptosis.
    Cory AH; Chen J; Cory JG
    Anticancer Res; 2006; 26(2A):1289-95. PubMed ID: 16619536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
    Cory AH; Cory JG
    Biochem Biophys Res Commun; 1998 Aug; 249(3):687-91. PubMed ID: 9731198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by inhibitors of nucleotide synthesis in deoxyadenosine-resistant leukemia L1210 cells that lack p53 expression.
    Cory AH; Hickerson DH; Cory JG
    Anticancer Res; 2000; 20(6B):4171-8. PubMed ID: 11205244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agents.
    Crenshaw TR; Cory JG
    Int J Oncol; 1999 Sep; 15(3):487-90. PubMed ID: 10427129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of cyclin cdk's, PKC and phosphoinositol 3-kinase pathways leads to augmentation of apoptosis in drug-resistant leukemia cells: evidence for interactive effects of flavopiridol, LY 294002, roscovitine,wortmannin and UCN-01.
    Cory AH; Somerville L; Cory JG
    Anticancer Res; 2005; 25(1A):101-6. PubMed ID: 15816525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines.
    He AW; Cory JG
    Anticancer Res; 1999; 19(1A):421-8. PubMed ID: 10226577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model.
    Chang MC; Tsai ET; Wu JY; Liao HF; Chen YJ; Kuo CD
    Anticancer Drugs; 2015 Jun; 26(5):508-17. PubMed ID: 25588161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
    Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
    Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3.
    de Mejia EG; Wang W; Dia VP
    Mol Nutr Food Res; 2010 Mar; 54(3):406-14. PubMed ID: 19937853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Amino-3-acetylquinoline-induced apoptosis of murine L1210 leukemia cells involves ROS-mitochondrial-mediated death signaling and activation of p38 MAPK.
    Jantová S; Repický A; Letasiová S; Cipák L
    Cell Biochem Funct; 2008; 26(5):609-19. PubMed ID: 18508389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.